FDA sets meetings to discuss Moderna and Pfizer COVID-19 vaccines

The United States Food and Drug Administration (FDA or USFDA) has scheduled meetings in order to approve two COVID-19 vaccines.
The agency has asked members of its vaccine advisory committee to reserve Dec. 17 and 18 for meetings. A source says those meetings are to discuss Moderna's vaccine.
Another meeting has already been set for Dec. 10, and will focus on Pfizer's application for emergency use approval. Both companies say their vaccines are 95% effective.